1. |
Van Cruchten S, Van Den Broeck W. Morphological and biochemical aspects of apoptosis, oncosis and necrosis [J]. Anat Histol Embryol, 2002; 31(4)∶214.
|
2. |
閆慶國,王文亮,黃高昇. 促細胞凋亡bax在膽管癌中的表達與意義 [J]. 第四軍醫大學學報,1997; 18(2)∶139.
|
3. |
閆慶國,王文亮,黃高昇. 膽管癌中抗凋亡基因bcl2的表達及意義 [J]. 臨床肝膽病雜志,1997; 13(4)∶194.
|
4. |
Ottilie S, Diaz JL, Horne W, et al. Dimerization properties of human BAD. Identification of a BH3 domain and analysis of its binding to mutant bcl2 and bclxL proteins [J]. J Biol Chem,1997; 272(49)∶30866.
|
5. |
Kelekar A, Chang BS, Harlan JE, et al. Bad is a BH3 domaincontaining protein that forms an inactivating dimer with bclxL [J]. Mol Cell Biol, 1997; 17(12)∶7040.
|
6. |
Hong JR, Wu JL.Induction of apoptotic death in cells via bad gene expression by infectious pancreatic necrosis virus infection [J]. Cell Death Differ, 2002; 9(2)∶113.
|
7. |
Ichinose M, Liu XH, Hagihara N, et al.Extracellular bad fused to toxin transport domains induces apoptosis [J]. Cancer Res, 2002; 62(5)∶1433.
|
8. |
Kohler T, Schill C, Deininger MW, et al.High bad and bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML) [J]. Leukemia, 2002; 16(1)∶22.
|
9. |
Schimmer AD, Hedley DW, Pham NA, et al. BAD induces apoptosis in cells overexpressing Bcl2 or BclxL without loss of mitochondrial membrane potential [J]. Leuk Lymphoma,2001; 42(3)∶429.
|
10. |
Hattori T, Ookawa N, Fujita R, et al. Heterodimerization of bcl2 and bclx(L) with bax and bad in colorectal cancer [J]. Acta Oncol, 2000; 39(4)∶495.
|